-
S404947-25mgSphynolactone-7.
-
S404947-5mgSphynolactone-7.
-
S463911-1mgDescriptionNatural product derived from plant source.}.
-
-
-
S132222-50mgRev-Erbα antagonist.
-
-
-
S102392-1mgStaurosporine is a potent PKC inhibitor for PKCα, PKCγ and PKCη with IC50 of 2 nM, 5 nM and 4 nM, less potent to PKCδ (20 nM), PKCε (73 nM) and little active to PKCζ (1086 nM). Phase 3.
-
S102392-5mgStaurosporine is a potent PKC inhibitor for PKCα, PKCγ and PKCη with IC50 of 2 nM, 5 nM and 4 nM, less potent to PKCδ (20 nM), PKCε (73 nM) and little active to PKCζ (1086 nM). Phase 3.
-
S425192-1mlStaurosporine is a potent PKC inhibitor for PKCα, PKCγ and PKCη with IC50 of 2 nM, 5 nM and 4 nM, less potent to PKCδ (20 nM), PKCε (73 nM) and little active to PKCζ (1086 nM). Phase 3.
-
S329507-100μgStellettamide A trifluoroacetate inhibits intrinsic tyrosine fluorescence in a concentration-dependent manner. Binds to calmodulin and inhibits Ca|2+|/calmodulin-dependent enzyme activities.